[1]
Lampe B, Luengas-Würzinger V, Weitz J, Roth S, Rawert F, Schuler E, Classen-von Spee S, Fix N, Baransi S, Dizdar A, Mallmann P, Schaser KD, Bogner A. Opportunities and Limitations of Pelvic Exenteration Surgery. Cancers. 2021 Dec 7:13(24):. doi: 10.3390/cancers13246162. Epub 2021 Dec 7
[PubMed PMID: 34944783]
[2]
Harris CA, Solomon MJ, Heriot AG, Sagar PM, Tekkis PP, Dixon L, Pascoe R, Dobbs BR, Frampton CM, Harji DP, Kontovounisios C, Austin KK, Koh CE, Lee PJ, Lynch AC, Warrier SK, Frizelle FA. The Outcomes and Patterns of Treatment Failure After Surgery for Locally Recurrent Rectal Cancer. Annals of surgery. 2016 Aug:264(2):323-9. doi: 10.1097/SLA.0000000000001524. Epub
[PubMed PMID: 26692078]
[3]
Brown KGM, Solomon MJ, Koh CE. Pelvic Exenteration Surgery: The Evolution of Radical Surgical Techniques for Advanced and Recurrent Pelvic Malignancy. Diseases of the colon and rectum. 2017 Jul:60(7):745-754. doi: 10.1097/DCR.0000000000000839. Epub
[PubMed PMID: 28594725]
[4]
PelvEx Collaborative. Palliative pelvic exenteration: A systematic review of patient-centered outcomes. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2019 Oct:45(10):1787-1795. doi: 10.1016/j.ejso.2019.06.011. Epub 2019 Jun 14
[PubMed PMID: 31255441]
Level 1 (high-level) evidence
[5]
Lee PJ, Meshkat B, Sasidharan P, Zahid A, Coker DJ, Solomon MJ. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series. ANZ journal of surgery. 2022 May:92(5):1038-1043. doi: 10.1111/ans.17275. Epub 2021 Oct 18
[PubMed PMID: 34661958]
[6]
He YJ, Zhou ZL, Qin QY, Huang BJ, Huang XY, Li JM, Zhu MM, Yao B, Wang DJ, Qiu JG, Wang H, Ma TH. [Pelvic exenteration for late complications of radiation-induced pelvic injury: a preliminary study]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery. 2023 Oct 25:26(10):940-946. doi: 10.3760/cma.j.cn441530-20230816-00053. Epub
[PubMed PMID: 37849264]
Level 2 (mid-level) evidence
[7]
Saqib SU, Raza MZ, Twigg J, Altan O, Bajwa AA. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration. Langenbeck's archives of surgery. 2023 Dec 16:409(1):9. doi: 10.1007/s00423-023-03206-7. Epub 2023 Dec 16
[PubMed PMID: 38102305]
Level 2 (mid-level) evidence
[8]
Koh CE, Solomon MJ, Brown KG, Austin K, Byrne CM, Lee P, Young JM. The Evolution of Pelvic Exenteration Practice at a Single Center: Lessons Learned from over 500 Cases. Diseases of the colon and rectum. 2017 Jun:60(6):627-635. doi: 10.1097/DCR.0000000000000825. Epub
[PubMed PMID: 28481857]
Level 3 (low-level) evidence
[9]
Cianci S, Arcieri M, Vizzielli G, Martinelli C, Granese R, La Verde M, Fagotti A, Fanfani F, Scambia G, Ercoli A. Robotic Pelvic Exenteration for Gynecologic Malignancies, Anatomic Landmarks, and Surgical Steps: A Systematic Review. Frontiers in surgery. 2021:8():790152. doi: 10.3389/fsurg.2021.790152. Epub 2021 Nov 30
[PubMed PMID: 34917648]
Level 1 (high-level) evidence
[10]
Bacalbasa N, Balescu I. Pelvic exenteration--reconsidering the procedure. Journal of medicine and life. 2015 Apr-Jun:8(2):146-9
[PubMed PMID: 25866569]
[11]
Lau YC, Jongerius K, Wakeman C, Heriot AG, Solomon MJ, Sagar PM, Tekkis PP, Frizelle FA. Influence of the level of sacrectomy on survival in patients with locally advanced and recurrent rectal cancer. The British journal of surgery. 2019 Mar:106(4):484-490. doi: 10.1002/bjs.11048. Epub 2019 Jan 16
[PubMed PMID: 30648734]
[12]
Young JM, Badgery-Parker T, Masya LM, King M, Koh C, Lynch AC, Heriot AG, Solomon MJ. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy. The British journal of surgery. 2014 Feb:101(3):277-87. doi: 10.1002/bjs.9392. Epub 2014 Jan 13
[PubMed PMID: 24420909]
Level 2 (mid-level) evidence
[13]
Quyn AJ, Solomon MJ, Lee PM, Badgery-Parker T, Masya LM, Young JM. Palliative Pelvic Exenteration: Clinical Outcomes and Quality of Life. Diseases of the colon and rectum. 2016 Nov:59(11):1005-1010
[PubMed PMID: 27749474]
Level 2 (mid-level) evidence
[14]
Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. The British journal of surgery. 2013 Jul:100(8):E1-33
[PubMed PMID: 23901427]
Level 3 (low-level) evidence
[15]
Kim SR, Lee YY, Brar H, Albert A, Covens A, Metser U, May T. Utility of 18F-FDG-PET/CT imaging in patients with recurrent gynecological malignancies prior to pelvic exenteration. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2019 Mar 28:():. pii: ijgc-2018-000091. doi: 10.1136/ijgc-2018-000091. Epub 2019 Mar 28
[PubMed PMID: 30923081]
Level 2 (mid-level) evidence
[16]
Johnstone CSH, Roberts D, Mathieson S, Steffens D, Koh CE, Solomon MJ, McLachlan AJ. Pain, pain management and related outcomes following pelvic exenteration surgery: a systematic review. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2023 Apr:25(4):562-572. doi: 10.1111/codi.16462. Epub 2023 Jan 8
[PubMed PMID: 36572393]
Level 1 (high-level) evidence
[17]
Persson P, Chong P, Steele CW, Quinn M. Prevention and management of complications in pelvic exenteration. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2022 Nov:48(11):2277-2283. doi: 10.1016/j.ejso.2021.12.470. Epub 2022 Jan 1
[PubMed PMID: 35101315]
[18]
Drami I, Lord AC, Sarmah P, Baker RP, Daniels IR, Boyle K, Griffiths B, Mohan HM, Jenkins JT. Preoperative assessment and optimisation for pelvic exenteration in locally advanced and recurrent rectal cancer: A review. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2022 Nov:48(11):2250-2257. doi: 10.1016/j.ejso.2021.11.007. Epub 2021 Nov 11
[PubMed PMID: 34922810]
[19]
Lyell NJ, Kitano M, Smith B, Gleisner AL, Backes FJ, Cheng G, McCarter MD, Abdel-Misih S, Jones EL. The effect of preoperative nutritional status on postoperative complications and overall survival in patients undergoing pelvic exenteration: A multi-disciplinary, multi-institutional cohort study. American journal of surgery. 2019 Aug:218(2):275-280. doi: 10.1016/j.amjsurg.2019.03.021. Epub 2019 Apr 4
[PubMed PMID: 30982571]
[21]
Austin KK, Solomon MJ. Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement. Diseases of the colon and rectum. 2009 Jul:52(7):1223-33. doi: 10.1007/DCR.0b013e3181a73f48. Epub
[PubMed PMID: 19571697]
[22]
Williams M, Perera M, Nouhaud FX, Coughlin G. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy. Investigative and clinical urology. 2021 Jan:62(1):111-120. doi: 10.4111/icu.20200176. Epub
[PubMed PMID: 33381928]
[23]
Chang TP, Chok AY, Tan D, Rogers A, Rasheed S, Tekkis P, Kontovounisios C. The Emerging Role of Robotics in Pelvic Exenteration Surgery for Locally Advanced Rectal Cancer: A Narrative Review. Journal of clinical medicine. 2021 Apr 5:10(7):. doi: 10.3390/jcm10071518. Epub 2021 Apr 5
[PubMed PMID: 33916490]
Level 3 (low-level) evidence
[24]
Waters PS, Peacock O, Warrier SK, Wakeman C, Eglinton T, Lynch AC, Frizelle FA, Heriot AG, McCormick J. Evolution of pelvic exenteration surgery- resectional trends and survival outcomes over three decades. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2019 Dec:45(12):2325-2333. doi: 10.1016/j.ejso.2019.07.015. Epub 2019 Jul 8
[PubMed PMID: 31303376]
[25]
Husain A, Curtin J, Brown C, Chi D, Hoskins W, Poynor E, Alektiar K, Barakat R. Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies. Gynecologic oncology. 2000 Aug:78(2):208-11
[PubMed PMID: 10926804]
[26]
CLARK DG, DANIEL WW, BRUNSCHWIG A. Intestinal fistulas following pelvic exenteration. American journal of obstetrics and gynecology. 1962 Jul 15:84():187-91
[PubMed PMID: 13879675]
[27]
Valle G, Ferraris G. Use of the omentum to contain the intestines in pelvic exenteration. Obstetrics and gynecology. 1969 Jun:33(6):772-5
[PubMed PMID: 5770549]
[28]
Schoenberg HW, Mikuta JJ. Technique for preventing urinary fistulas following pelvic exenteration and ureteroileostomy. The Journal of urology. 1973 Sep:110(3):294-5
[PubMed PMID: 4725729]
[29]
PelvExCollaborative. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy. Annals of surgery. 2019 Nov:270(5):899-905. doi: 10.1097/SLA.0000000000003533. Epub
[PubMed PMID: 31634184]
[30]
Vigneswaran HT, Schwarzman LS, Madueke IC, David SM, Nordenstam J, Moreira D, Abern MR. Morbidity and Mortality of Total Pelvic Exenteration for Malignancy in the US. Annals of surgical oncology. 2021 May:28(5):2790-2800. doi: 10.1245/s10434-020-09247-2. Epub 2020 Oct 26
[PubMed PMID: 33105501]
[31]
Kazi M, Rohila J, Kumar NA, Bankar S, Engineer R, Desouza A, Saklani A. Urinary reconstruction following total pelvic exenteration for locally advanced rectal cancer: complications and factors affecting outcomes. Langenbeck's archives of surgery. 2021 Mar:406(2):329-337. doi: 10.1007/s00423-021-02086-z. Epub 2021 Feb 1
[PubMed PMID: 33527204]
[32]
PelvEx Collaborative. Minimally invasive surgery techniques in pelvic exenteration: a systematic and meta-analysis review. Surgical endoscopy. 2018 Dec:32(12):4707-4715. doi: 10.1007/s00464-018-6299-5. Epub 2018 Jul 17
[PubMed PMID: 30019221]
Level 1 (high-level) evidence
[33]
PelvEx Collaborative. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration. Annals of surgery. 2019 Feb:269(2):315-321. doi: 10.1097/SLA.0000000000002528. Epub
[PubMed PMID: 28938268]
[34]
PelvEx Collaborative. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer. The British journal of surgery. 2018 May:105(6):650-657. doi: 10.1002/bjs.10734. Epub 2018 Mar 12
[PubMed PMID: 29529336]
[35]
PelvEx Collaborative. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer. BJS open. 2019 Aug:3(4):516-520. doi: 10.1002/bjs5.50153. Epub 2019 Mar 6
[PubMed PMID: 31388644]
[36]
PelvEx Collaborative. Management strategies for patients with advanced rectal cancer and liver metastases using modified Delphi methodology: results from the PelvEx Collaborative. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2020 Sep:22(9):1184-1188. doi: 10.1111/codi.15007. Epub 2020 Mar 2
[PubMed PMID: 32043753]
[37]
PelvEx Collaborative. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 2020 Oct:22(10):1258-1262. doi: 10.1111/codi.15064. Epub 2020 May 12
[PubMed PMID: 32294308]